Patents Assigned to Squarex, LLC
  • Dermal patches and glass swabs for application of topical immunosensitizers
    Patent number: 12642948
    Abstract: Unit dosage forms, devices, and kits for topical delivery of topical immunosensitizers are provided. These include dermal patches, glass swabs, and kits containing a dermal patch and a glass swab. Among other advantages, the unit dosage forms, devices, and kits presented herein deliver a more consistent and controlled volume of drug solution, prevent underdosing and overdosing, prevent or discourage repeat dosing, and provide a more consistent skin area to which the drug solution is applied.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: June 2, 2026
    Assignee: Squarex, LLC
    Inventor: Hugh McTavish
  • Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
    Patent number: 12128098
    Abstract: A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site other than at the site of an HSV lesion to induce a DTH response during one or more outbreaks of the HSV infection. The method reduces the number of HSV outbreaks in persons experiencing outbreaks.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: October 29, 2024
    Assignee: Squarex, LLC
    Inventor: Hugh McTavish
  • Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
    Patent number: 10744084
    Abstract: A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: August 18, 2020
    Assignees: Squarex, LLC, Bioventures, LLC
    Inventors: Hugh McTavish, Thomas Dag Horn, Sandra Marchese Johnson
  • Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
    Patent number: 10245314
    Abstract: A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
    Type: Grant
    Filed: August 20, 2017
    Date of Patent: April 2, 2019
    Assignee: Squarex, LLC
    Inventor: Hugh McTavish